Research Article

Inhibitory Activity of Pyrroloisoxazolidine Derivatives against Chlamydia trachomatis

Table 1

The IC50 values (μM) and cell viability of pyrroloisoxazolidine-treated uninfected cells. IC50 values are presented as the mean (95% confidence interval). indicates statistically significant () difference of cell proliferation activity between compound-treated and DMSO-treated cells.

EntryIC50 (μM) Mean (95% confidence interval)Cell viability (%)
R1R2R3R4Ct L2Ct D32 μM

1PhPhPhPh7.25 (6.48 ~ 8.11)9.31 (8.42 ~ 10.28)100.92
2PhPhPh8.69 (7.59 ~ 9.93)9.73 (8.83 ~ 10.72)98.32
3PhPhPh8.67 (6.40 ~ 11.73)20.91 (17.80 ~ 24.58)99.89
4PhPh11.17 (7.49 ~ 16.64)>3297.49
5PhPh15.49 (8.04 ~ 29.87)>3295.17
6PhPh9.08 (4.66 ~ 17.68)16.85 (12.61 ~ 22.52)
7PhPhPh19.06 (12.84 ~ 28.30)>32
8PhPh25.42 (12.62 ~ 51.22)28.60 (18.77 ~ 43.58)101.81
9Ph>3219.59 (13.18 ~ 29.11)96.51
10Ph17.35 (13.02 ~ 23.10)15.43 (12.94 ~ 18.40)
11PhPh>3223.54 (16.13 ~ 34.35)99.70
12PhPh17.52 (11.07 ~ 27.73)12.51 (9.86 ~ 15.87)103.85
13PhPh>3216.29 (12.03 ~ 22.06)95.73
14PhPh16.78 (13.61 ~ 20.70)16.31 (12.81 ~ 20.77)97.95
15PhPh9.77 (8.45 ~ 11.30)12.22 (7.94 ~ 18.80)103.64
16PhPh13.52 (12.86 ~ 14.21)5.93 (4.51 ~ 7.79)96.53
17PhPh>3227.57 (20.56 ~ 36.98)113.63
18Ph>3220.97 (16.41 ~ 26.79)105.86